Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combigan Safety in Glaucoma or Ocular Hypertension
NCT00651612Phase 3Completed
- Sponsor
- Allergan
- Start
- Nov 2005
- Primary completion
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of brimonidine tartrate + timolol maleate in Glaucoma, ocular hypertension, sponsored by Allergan. Started Nov 2005; status: completed.
02
Drugs
brimonidine tartrate + timolol maleate
03
Conditions
Glaucomaocular hypertension
Beyond the preview
Go deeper on NCT00651612.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00651612.